MRK vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
VS
Tesla, Inc. · Consumer Cyclical
$400.49
-1.1% upside to fair value
Grade D
QuantHub Verdict
TSLA has more upside to fair value
(-1.1%).
MRK trades at a lower forward P/E
(32.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
TSLA |
| Current Price |
$113.87 |
$400.49 |
| Fair Value Estimate |
$100.14 |
$396.15 |
| Upside to Fair Value |
-12.1%
|
-1.1%
|
| Market Cap |
$281.2B |
$1,504.1B |
| Forward P/E |
32.0x
|
334.1x
|
| EV / EBITDA |
17.3x
|
124.0x
|
| Price / Sales |
4.3x
|
15.4x
|
| Price / FCF |
19.9x
|
214.9x
|
| Revenue Growth YoY |
+4.3%
|
+15.8%
|
| Gross Margin |
75.9%
|
19.1%
|
| Operating Margin |
27.6%
|
5.0%
|
| Return on Equity |
17.9%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.02%
|
0.47%
|
| Analyst Consensus |
Hold
|
Buy
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Tesla, Inc. is a leading global electric vehicle manufacturer and energy solutions provider, led by CEO Elon Musk since 2008. The company maintains a strong position in the EV market with a unique fast-charging and software ecosystem, although its EV market share is declining amid intensifying competition. Tesla's business quality is medium due to its narrowing moat and modest profitability, with…
Accumulation Zones
| Metric |
MRK |
TSLA |
| Zone Low |
$75.11 |
$297.11 |
| Zone High |
$85.12 |
$336.73 |
| In Buy Zone? |
No
|
No
|